KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Non-Current Assets (2016 - 2025)

Merck (MRK) has disclosed Non-Current Assets for 17 consecutive years, with $125.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets changed N/A to $125.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $125.0 million, a N/A change, with the full-year FY2025 number at $125.0 million, changed N/A from a year prior.
  • Non-Current Assets was $125.0 million for Q4 2025 at Merck, up from -$47.6 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $80.5 billion in Q2 2025 to a low of -$47.6 billion in Q3 2025.
  • A 5-year average of $34.4 billion and a median of $73.4 billion in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 344.28% in 2021, then plummeted 153.98% in 2024.
  • Merck's Non-Current Assets stood at $75.4 billion in 2021, then fell by 2.64% to $73.4 billion in 2022, then increased by 1.46% to $74.5 billion in 2023, then tumbled by 154.17% to -$40.4 billion in 2024, then soared by 100.31% to $125.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Non-Current Assets are $125.0 million (Q4 2025), -$47.6 billion (Q3 2025), and $80.5 billion (Q2 2025).